AbstractImmune activation is a hallmark of systemic sclerosis (SSc). However, the immunological alterations that occur in preclinical and non-fibrotic SSc and that differentiate these subjects from those with primary Raynaud's phenomenon (PRP) or healthy controls (HC) are poorly defined. We isolated CD56+ (NK/NKT-like) cells from HC, patients with PRP, early SSc (EaSSc) and definite SSc without skin or lung fibrosis. Cytokine production upon different activating stimuli was measured via a multiplex immuno assay. Clearly discriminative patterns among the different stages of SSc were most markedly observed after TLR1/2 stimulation, with increased IL-6, TNF-α and MIP-1α/CCL3 production in definite SSc patients as compared to HC and/or PRP. Ini...
Profound alterations characterize the adaptive immune response in systemic sclerosis, and several la...
OBJECTIVE: Patients with definite systemic sclerosis (SSc) who lack fibrotic features can be stratif...
Mitogen-stimulated IL-2, IFN-gamma, TNF-alpha (type 1 cytokines), and IL-10 (type 2 cytokine) produc...
Immune activation is a hallmark of systemic sclerosis (SSc). However, the immunological alterations ...
AbstractImmune activation is a hallmark of systemic sclerosis (SSc). However, the immunological alte...
The development of unrestrained fibrosis in the skin and internal organs is the hallmark of systemic...
OBJECTIVE: Systemic sclerosis (SSc) has the highest case-specific mortality of any rheumatic disease...
Background Systemic sclerosis (SSc) is an autoimmune disease and accumulating evidence suggests a ro...
Systemic sclerosis (SSc) is characterized by activation of fibroblasts with extensive deposition of ...
Natural killer (NK) cells are innate immune effectors that produce various immunoregulatory cytokine...
Systemic sclerosis (SSc) is an idiopathic systemic autoimmune disease. It is characterized by a tria...
INTRODUCTION: Early systemic sclerosis (SSc) is characterized by Raynaud's phenomenon together with...
OBJECTIVE: To investigate the ex vivo pro-inflammatory properties of classical and non-classical mon...
Systemic sclerosis (SSc) is a chronic disease characterized by microvasculopathy, autoantibodies (au...
Our objective was to investigate the phenotype of helper T cells in the peripheral blood of patients...
Profound alterations characterize the adaptive immune response in systemic sclerosis, and several la...
OBJECTIVE: Patients with definite systemic sclerosis (SSc) who lack fibrotic features can be stratif...
Mitogen-stimulated IL-2, IFN-gamma, TNF-alpha (type 1 cytokines), and IL-10 (type 2 cytokine) produc...
Immune activation is a hallmark of systemic sclerosis (SSc). However, the immunological alterations ...
AbstractImmune activation is a hallmark of systemic sclerosis (SSc). However, the immunological alte...
The development of unrestrained fibrosis in the skin and internal organs is the hallmark of systemic...
OBJECTIVE: Systemic sclerosis (SSc) has the highest case-specific mortality of any rheumatic disease...
Background Systemic sclerosis (SSc) is an autoimmune disease and accumulating evidence suggests a ro...
Systemic sclerosis (SSc) is characterized by activation of fibroblasts with extensive deposition of ...
Natural killer (NK) cells are innate immune effectors that produce various immunoregulatory cytokine...
Systemic sclerosis (SSc) is an idiopathic systemic autoimmune disease. It is characterized by a tria...
INTRODUCTION: Early systemic sclerosis (SSc) is characterized by Raynaud's phenomenon together with...
OBJECTIVE: To investigate the ex vivo pro-inflammatory properties of classical and non-classical mon...
Systemic sclerosis (SSc) is a chronic disease characterized by microvasculopathy, autoantibodies (au...
Our objective was to investigate the phenotype of helper T cells in the peripheral blood of patients...
Profound alterations characterize the adaptive immune response in systemic sclerosis, and several la...
OBJECTIVE: Patients with definite systemic sclerosis (SSc) who lack fibrotic features can be stratif...
Mitogen-stimulated IL-2, IFN-gamma, TNF-alpha (type 1 cytokines), and IL-10 (type 2 cytokine) produc...